PBAXU

Phoenix Biotech Aquisition (PBAXU)

Phoenix Biotech Aquisition Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PBAXU

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/22	21 : 00	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/05/18	06 : 09	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/05/16	19 : 28	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/05/07	06 : 11	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/05/04	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/05/02	13 : 16	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/05/02	05 : 45	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/05/02	05 : 13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/04/27	05 : 31	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/04/16	05 : 36	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/04/11	05 : 06	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/04/04	06 : 27	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/04/02	20 : 12	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/04/02	20 : 07	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/04/02	10 : 54	Edgar (US Regulatory)	Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/03/28	10 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/03/28	10 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/28	23 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/27	22 : 27	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/27	11 : 37	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/24	07 : 13	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/21	07 : 18	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/17	09 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/17	09 : 29	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/17	09 : 28	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/15	02 : 14	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/15	02 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/13	06 : 16	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/13	06 : 14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation
2024/02/06	20 : 20	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:PBAXU	Phoenix Biotech Aquisition Corporation